Your browser doesn't support javascript.
loading
Large T Antigen-Specific Cytotoxic T Cells Protect Against Dendritic Cell Tumors through Perforin-Mediated Mechanisms Independent of CD4 T Cell Help.
Duval, Anaïs; Fuertes Marraco, Silvia A; Schwitter, Dominik; Leuenberger, Line; Acha-Orbea, Hans.
Afiliação
  • Duval A; Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
  • Fuertes Marraco SA; Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
  • Schwitter D; Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
  • Leuenberger L; Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
  • Acha-Orbea H; Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
Front Immunol ; 5: 338, 2014.
Article em En | MEDLINE | ID: mdl-25101081
Our newly generated murine tumor dendritic cell (MuTuDC) lines, generated from tumors developing in transgenic mice expressing the simian virus 40 large T antigen (SV40LgT) and GFP under the DC specific promoter CD11c, reproduce the phenotypic and functional properties of splenic wild type CD8α(+) conventional DCs. They have an immature phenotype with low co-stimulation molecule expression (CD40, CD70, CD80, and CD86) that is upregulated after activation with toll-like receptor ligands. We observed that after transfer into syngeneic C57BL/6 mice, MuTuDC lines were quickly rejected. Tumors grew efficiently in large T transgene-tolerant mice. To investigate the immune response toward the large T antigen that leads to rejection of the MuTuDC lines, they were genetically engineered by lentiviral transduction to express luciferase and tested for the induction of DC tumors after adoptive transfer in various gene deficient recipient mice. Here, we document that the MuTuDC line was rejected in C57BL/6 mice by a CD4 T cell help-independent, perforin-mediated CD8 T cell response to the SV40LgT without pre-activation or co-injection of adjuvants. Using depleting anti-CD8ß antibodies, we were able to induce efficient tumor growth in C57BL/6 mice. These results are important for researchers who want to use the MuTuDC lines for in vivo studies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça